Meningitis: Ceftriaxone was an effective treatment
|
|
|
Clinical bottom line (level 4)
-
In the treatment of bacterial meningitis, ceftriaxone appeared
as effective as ampicillin/chloramphenicol
(NNT =
17
at
unknown)
|
|
Girgis et al:
Lancet
1989;
2:
510-
|
Expires
January 2003
|
The study
Unblinded ?concealed ?randomised
trial
with
intention-to-treat
Setting: Meningitis ward, Egypt
100 patients
(aged
21.7 years (30 cases were 'adult, 15 cases 'paediatric'),
?%
male)
acute bacterial meningitis (by Gram stain of
CSF)
Control Group: (n = 50, 50 analysed):
ampicillin
and
chloramphenicol
Experimental Group: (n = 50, 50 analysed):
ceftriaxone
100mg/kg (max 4g) OD for 6 days
100% followed for
? mortality
The evidence
| Outcome |
Time to outcome |
CER | EER | RRR (95% CI) | ARR (95% CI) | NNT (95% CI) |
| mortality (all ages)
|
unknown |
10 (20%) |
7 (14%) |
30% (-69% to
71%) |
6.0% (-8.7% to
21%) |
17
(NNT = 5 to infinity;
NNH =
12
to infinity)
|
| mortality (adults)
|
unknown |
1 (6.7%) |
1 (6.7%) |
0% (-1350% to
93%) |
0% (-17.9% to
17.9%) |
-
(NNT = 6 to infinity;
NNH =
6
to infinity)
|
Comments
- Details on population type and neurological sequelae are lacking.
Citation
-
Girgis
NI,
Farid
Z,
Bishay
E:
Ceftriaxone in Bacterial Meningitis.
Lancet
1989;
2:
510-
Contributor: Bob Phillips and Clare Wotton,
January 2000
Reviewer: Andreas Cerny
Clinical Question.
| Patient |
meningitis |
| Intervention or Exposure |
ceftriaxone OD |
| Comparison |
standard therapy; chloramphenicol &
penicillin |
| Outcome |
mortality |
|
|